MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-15-0035405
Lysten Global Pharmaceuticals Private Limited
Lysten Global Pharmaceuticals Private Limited - pharma in Kolhapur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹8,000
▼ 97% YoY
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹55 Lakh
No open charges
Company age
11 yrs
Est. 2015
Employees · EPFO
36
Provident fund records
Directors on board
6
As per MCA filings
Active GSTINs
1
GST registered
About Lysten Global Pharmaceuticals Private Limited
Data last updated:
Lysten Global Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2015PTC156013. Its GSTIN is 27AACCL9050G1ZH (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Vikas Lalasaheb Patil and Nitin Parshram Jadhav.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at S. No. 235 Flat No. 5 Visava Apartment B Ward Hanuman Nagar, Kolhapur, Maharashtra, India – 416007.
The company has about 36 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹55 Lakh on record.
Lysten Global Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-15-0035405). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239PN2015PTC156013
Registration Number 156013
Incorporation Date 31 July 2015
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-15-0035405
Key People
Vikas Lalasaheb Patil Director Nitin Parshram Jadhav Director Sachin Lalasaheb Patil Director Recognitions & Rankings of Lysten Global Pharmaceuticals
Contact details
Lysten Global Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS. No. 235 Flat No. 5 Visava Apartment B Ward Hanuman Nagar, Kolhapur, Maharashtra, India – 416007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lysten Global Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Lysten Global Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Lysten Global Pharmaceuticals Private Limited
FY 2023 filings availableLysten Global Pharmaceuticals Private Limited reported revenue of ₹8,000 (down 97% YoY) for FY 2023.
Revenue · FY 2023
₹8,000 ▼ 97%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 97%
3 years · compounded
▼ 91%
5 years · compounded
▼ 75%
Revenue has declined at a compounded annual rate (CAGR) of 75% over five years, including a 97% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lysten Global Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lysten Global Pharmaceuticals Private Limited
Lysten Global Pharmaceuticals has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Lalasaheb Patil | Director | 13 Jul 2016 | 10 Years 3 Months | Current |
| Nitin Parshram Jadhav | Director | 31 Jul 2015 | 11 Years 3 Months | Current |
| Sachin Lalasaheb Patil | Director | 31 Jul 2015 | 11 Years 3 Months | Current |
| Vijay Shamrao Patil | Director | 04 Nov 2015 | 10 Years 11 Months | Current |
| Shilpa Nitin Jadhav | Director | 21 Nov 2015 | 10 Years 11 Months | Current |
| Bahubali Kumar Borgave | Director | 13 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Lysten Global Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genx Pharma Private Limited | ₹8,328 (FY 2025) | Hyderabad, Telangana, India | ||||
| Nivera Pharmaceuticals Private Limited | ₹8,031 (FY 2023) | -70.0% | Bangalore, Karnataka, India | |||
| Vincit Lifesciences Private Limited | ₹8,017 (FY 2020) | -97.0% | Surat, Gujarat, India | |||
| Lysten Global Pharmaceuticals Private Limitedthis company | ₹8,000 (FY 2023) | -97.0% | 36 | Kolhapur, Maharashtra, India | ||
| Canris Pharma India Private Limited | ₹7,573 (FY 2020) | -98.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Lysten Global Pharmaceuticals Private Limited, buy the company report.
Auditor
Lysten Global Pharmaceuticals Private Limited is audited by PRAKASH SHELAKE AND ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAKASH SHELAKE AND ASSOCIATES | FY 2020 | 133491W |
Shareholding
The shareholding of Lysten Global Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Lysten Global Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹55 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2017 | 100120028 | Indian Bank | ₹55 Lakh | Satisfied |
To see the full charge records of Lysten Global Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Lysten Global Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lysten Global Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lysten Global Pharmaceuticals Private Limited has a workforce of 36 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
36
Active EPFO establishments
1
Employee growth
80%
GST
Lysten Global Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCL9050G1ZH | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lysten Global Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lysten Global Pharmaceuticals Private Limited has 15 board changes on record since 2015: 6 appointments and 9 cessations. The latest: Sneha Bahubali Borgave ceased to be Director on 18 Oct 2022.
AGM
Lysten Global Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Charges
A charge registered on 31 Jan 2017 via Charge ID 100120028 with Indian Bank was fully satisfied on 16 May 2023.
Filing
Lysten Global Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.
Ceased
Sneha Bahubali Borgave ceased to be Director.
Ceased
Nitin Parshram Jadhav ceased to be Director.
Ceased
Sachin Lalasaheb Patil ceased to be Director.
Ceased
Shilpa Nitin Jadhav ceased to be Director.
Ceased
Ramesh Shripati Patil ceased to be Director.
Charges
A charge with Indian Bank amounted to Rs. 55.00 Lakh with Charge ID 100120028 was registered on 31 Jan 2017.
Ceased
Bahubali Kumar Borgave ceased to be Additional Director.
Ceased
Vikas Lalasaheb Patil ceased to be Additional Director.
Appointed
Bahubali Kumar Borgave was appointed as Director.
8 earlier events are in the company report.
Frequently asked questions
Lysten Global Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 July 2015 (11+ years old) and is registered under CIN U24239PN2015PTC156013.
Lysten Global Pharmaceuticals has 6 current directors:
- Vikas Lalasaheb Patil - Director
- Nitin Parshram Jadhav - Director
- Sachin Lalasaheb Patil - Director
- Vijay Shamrao Patil - Director
- Shilpa Nitin Jadhav - Director
- Bahubali Kumar Borgave - Director
The latest financial statements of Lysten Global Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Lysten Global Pharmaceuticals is 27AACCL9050G1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lysten Global Pharmaceuticals is U24239PN2015PTC156013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lysten Global Pharmaceuticals was incorporated on 31 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Lysten Global Pharmaceuticals by revenue are Genx Pharma Private Limited, Nivera Pharmaceuticals Private Limited, Vincit Lifesciences Private Limited, Canris Pharma India Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sneha Bahubali Borgave ceased to be Director on 18 Oct 2022. Nitin Parshram Jadhav ceased to be Director on 15 Jul 2021. Sachin Lalasaheb Patil ceased to be Director on 15 Jul 2021. Lysten Global Pharmaceuticals has 15 board changes on record in total.
Yes, Lysten Global Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-15-0035405).
The registered office of Lysten Global Pharmaceuticals is at S. No. 235 Flat No. 5 Visava Apartment B Ward Hanuman Nagar, Kolhapur, Maharashtra, India – 416007.
Lysten Global Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages